TASE:BONS

٢٨ أبريل ٢٠٢٢

Oramed Pharm - is a clinical stage biopharmaceutical company.

2022/3 Planned launch of MesenCure multinational phase III clinical trial; and phase II/III clinical trial in the US evaluating the safety and efficacy of BonoFillTM injectable live bone graft for bone regeneration.

٢٨ أبريل ٢٠٢٢

ملاحظة

It's Bonus Biogroup, of course! Wrong company name in description was mistakenly copy-pasted (!)